Human Papillomavirus Antibody Reference Reagents for Use in Postvaccination Surveillance Serology

被引：16

作者：

Bissett, Sara L. ^{[1
]}

Wilkinson, Dianna ^{[2
]}

Tettmar, Kate I. ^{[3
]}

Jones, Nicky ^{[2
]}

Stanford, Elaine ^{[4
]}

Panicker, Gitika ^{[5
]}

Faust, Helena ^{[6
]}

Borrow, Ray ^{[4
]}

Soldan, Kate ^{[1
]}

Unger, Elizabeth R. ^{[5
]}

Dillner, Joakim ^{[6
]}

Minor, Philip ^{[2
]}

Beddows, Simon ^{[1
]}

机构：

[1] Hlth Protect Agcy, Ctr Infect, London, England

[2] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England

[3] NHS Blood & Transplant, London, England

[4] Hlth Protect Agcy, Vaccine Evaluat & Seroepidemiol Unit, Manchester, Lancs, England

[5] Ctr Dis Control & Prevent, Global WHO HPV Reference Lab, Atlanta, GA USA

[6] Malmo Univ Hosp, Global WHO HPV Reference Lab, Malmo, Sweden

来源：

CLINICAL AND VACCINE IMMUNOLOGY | 2012年 / 19卷 / 03期

基金：

英国医学研究理事会;

关键词：

PARTICLE VACCINE; HPV; NEUTRALIZATION; VALIDATION; INFECTION; EFFICACY; WOMEN; ASSAY;

D O I：

10.1128/CVI.05641-11

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Suitably controlled serosurveillance surveys are essential for evaluating human papillomavirus (HPV) immunization programs. A panel of plasma samples from 18-year-old females was assembled, the majority of the samples being from recipients of the bivalent HPV vaccine. Antibody specificities were evaluated by three independent laboratories, and 3 pools that displayed no antibodies to any HPV type tested or intermediate or high levels of antibody to HPV16, HPV18, HPV31, and HPV45 were created. These pools will be useful as control reagents for HPV serology.

引用

页码：449 / 451

页数：3

共 22 条

[1] [Anonymous], 2010, HUM PAP LAB MAN
[2] [Anonymous], 2009, HUMAN PAPILLOMAVIRUS
[3] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
Brown, Darron R.
Kjaer, Susanne K.
Sigurdsson, Kristjan
Iversen, Ole-Erik
Hernandez-Avila, Mauricio
Wheeler, Cosette M.
Perez, Gonzalo
Koutsky, Laura A.
Tay, Eng Hseon
Garcia, Patricia
Ault, Kevin A.
Garland, Suzanne M.
Leodolter, Sepp
Olsson, Sven-Eric
Tang, Grace W. K.
Ferris, Daron G.
Paavonen, Jorma
Steben, Marc
Bosch, F. Xavier
Dillner, Joakim
Joura, Elmar A.
Kurman, Robert J.
Majewski, Slawomir
Munoz, Nubia
Myers, Evan R.
Villa, Luisa L.
Taddeo, Frank J.
Roberts, Christine
Tadesse, Amha
Bryan, Janine
Lupinacci, Lisa C.
Giacoletti, Katherine E. D.
Sings, Heather L.
James, Margaret
Hesley, Teresa M.
Barra, Eliav
[J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) : 926 - 935
[4] Buck CB, 2005, METH MOLEC MED, V119, P445
[5] Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine
Dessy, Francis J.
Giannini, Sandra L.
Bougelet, Catherine A.
Kemp, Troy J.
David, Marie-Pierre M.
Poncelet, Sylviane M.
Pinto, Ligia A.
Wettendroff, Martine A.
[J]. HUMAN VACCINES, 2008, 4 (06): : 425 - 434
[6] Optimization and validation of a multiplexed Luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18
Dias, D
Van Doren, J
Schlottmann, S
Kelly, S
Puchalski, D
Ruiz, W
Boerckel, P
Kessler, J
Antonello, JM
Green, T
Brown, M
Smith, J
Chirmule, N
Barr, E
Jansen, KU
Esser, MT
[J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (08) : 959 - 969
[7] Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
Draper, Eve
Bissett, Sara L.
Howell-Jones, Rebecca
Edwards, Debbie
Munslow, Graham
Soldan, Kate
Beddows, Simon
[J]. VACCINE, 2011, 29 (47) : 8585 - 8590
[8] Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads
Faust, Helena
Knekt, Paul
Forslund, Ola
Dillner, Joakim
[J]. JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1840 - 1848
[9] The first international standard for antibodies to HPV 16
Ferguson, Morag
Wilkinson, Dianna E.
Heath, Alan
Matejtschuk, Paul
[J]. VACCINE, 2011, 29 (38) : 6520 - 6526
[10] Frazer Ian H, 2010, Gynecol Oncol, V118, pS8, DOI 10.1016/j.ygyno.2010.04.003

← 1 2 3 →